These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 38196736)
1. Correlation Between DCAMKL-1 Protein Expression and K-ras Gene Mutation in Colorectal Cancer. Wu X; Li S; Yang Y; Hu J; Yang T Cancer Manag Res; 2024; 16():11-21. PubMed ID: 38196736 [TBL] [Abstract][Full Text] [Related]
2. Relationships among Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081 [TBL] [Abstract][Full Text] [Related]
3. Relationship between mismatch repair protein, Fan JZ; Wang GF; Cheng XB; Dong ZH; Chen X; Deng YJ; Song X World J Clin Cases; 2021 Apr; 9(11):2458-2468. PubMed ID: 33889611 [TBL] [Abstract][Full Text] [Related]
4. miR-211 regulates the expression of Chang CC; Lin CC; Wang CH; Huang CC; Ke TW; Wei PL; Yeh KT; Hsu KC; Hsu NY; Cheng YW Oncol Lett; 2018 May; 15(5):8107-8117. PubMed ID: 29731918 [TBL] [Abstract][Full Text] [Related]
5. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K- Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239 [TBL] [Abstract][Full Text] [Related]
6. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients. Jin M; Long ZW; Yang J; Lin X Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432 [TBL] [Abstract][Full Text] [Related]
7. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
8. p16 protein is upregulated in a stepwise fashion in colorectal adenoma and colorectal carcinoma. Al-Ahwal M; Gomaa W; Emam E; Qari Y; Buhmeida A; Radwi S; Al-Maghrabi B; Al-Qahtani M; Al-Maghrabi J Saudi J Gastroenterol; 2016 Nov; 22(6):435-440. PubMed ID: 27976639 [TBL] [Abstract][Full Text] [Related]
9. Clinical retrospective study on the expression of the PD-L1 molecule in sporadic colorectal cancer and its correlation with K-ras gene mutations in Chinese patients. Xu J; Zhao W; Liao K; Tu L; Jiang X; Dai H; Yu Y; Xiong Q; Xiong Z Am J Transl Res; 2021; 13(6):6142-6155. PubMed ID: 34306353 [TBL] [Abstract][Full Text] [Related]
10. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas. Fujita M; Fukui H; Kusaka T; Morita K; Fujii S; Ueda Y; Chiba T; Sakamoto C; Kawamata H; Fujimori T J Gastroenterol Hepatol; 2000 Nov; 15(11):1277-81. PubMed ID: 11129221 [TBL] [Abstract][Full Text] [Related]
11. Peptide nucleic acid clamp PCR: a novel K-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes. Taback B; Bilchik AJ; Saha S; Nakayama T; Wiese DA; Turner RR; Kuo CT; Hoon DS Int J Cancer; 2004 Sep; 111(3):409-14. PubMed ID: 15221969 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients. Shen H; Yuan Y; Hu HG; Zhong X; Ye XX; Li MD; Fang WJ; Zheng S World J Gastroenterol; 2011 Feb; 17(6):809-16. PubMed ID: 21390154 [TBL] [Abstract][Full Text] [Related]
13. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers. Wang JY; Hsieh JS; Chang MY; Huang TJ; Chen FM; Cheng TL; Alexandersen K; Huang YS; Tzou WS; Lin SR World J Surg; 2004 Jul; 28(7):721-6. PubMed ID: 15185002 [TBL] [Abstract][Full Text] [Related]
14. [Correlation of Ma QZ; Yang YW; Ma YL; Liao SP; Zheng YJ; Zhang S; Cao YY; Zhang J; Wang YF Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 50(1):61-65. PubMed ID: 31037906 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer. Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258 [TBL] [Abstract][Full Text] [Related]
16. Critical Role of p53 and K-ras in the Diagnosis of Early Colorectal Cancer: a One-year, Single-center Analysis. Lu HY; Lin RT; Zhou GX; Yu TM; Liu ZJ Int J Med Sci; 2017; 14(11):1154-1162. PubMed ID: 29104470 [No Abstract] [Full Text] [Related]
17. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers. Park HW; Kang HC; Kim IJ; Jang SG; Kim K; Yoon HJ; Jeong SY; Park JG Int J Cancer; 2007 Jan; 120(1):7-12. PubMed ID: 17013898 [TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological characteristics, MSI and K-ras gene mutations of double primary malignancies associated with colorectal cancer]. Li Q; Zhang B; Niu FN; Ye Q; Chen J; Fan XS Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(4):301-306. PubMed ID: 32075360 [No Abstract] [Full Text] [Related]
19. Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis. Rao B; Gao Y; Huang J; Gao X; Fu X; Huang M; Yao J; Wang J; Li W; Zhang J; Liu H; Wang L; Wang J Int J Colorectal Dis; 2011 May; 26(5):593-601. PubMed ID: 21404058 [TBL] [Abstract][Full Text] [Related]